Percutaneous decannulation of venoarterial extracorporeal membrane oxygenation using the Manta vascular closure device: A systematic review and meta‐analysis

• Published in: Artificial organs Vol. 47; no. 9; pp. 1431 - 1441
• Main Authors: Ng, Jun Jie, Lee, Stefanie H. T., Lim, Joseph K. W., Chan, Karen K. W., Lim, Mark D. S., Ahmed, Mohamed A. I., Loh, Stanley E. K., Choong, Andrew M. T. L.
• Format: Journal Article
• Language: English
• Published: United States Wiley Subscription Services, Inc 01.09.2023
• Subjects: Amputation; Bleeding; Complications; Device Removal - adverse effects; Extracorporeal membrane oxygenation; Extracorporeal Membrane Oxygenation - methods; Hemorrhage - etiology; Humans; Membranes; Meta-analysis; Oxygenation; Retrospective Studies; Shock, Cardiogenic - complications; Shock, Cardiogenic - surgery; Systematic review; Treatment Outcome; Vascular Closure Devices - adverse effects; Wounds; ECMO; meta-analysis; decannulation; percutaneous; systematic review
• ISSN: 0160-564X; 1525-1594; 1525-1594
• DOI: 10.1111/aor.14554

To perform a systematic review and meta-analysis of the techniques and outcomes associated with percutaneous decannulation of venoarterial extracorporeal membrane oxygenation (VA-ECMO) using the Manta vascular closure device. Peripheral VA-ECMO can be used to treat critically ill patients with conditions such as refractory cardiogenic shock. After percutaneous implantation of VA-ECMO, VA-ECMO can also be decannulated completely percutaneously by using a vascular closure device. The Manta vascular closure device is a dedicated device used in the closure of large-bore arteriotomies by sandwiching the arteriotomy with an intra-arterial toggle and an extraluminal collagen plug. We performed a thorough literature search using various electronic databases. We included studies that reported outcomes after peripheral femorofemoral VA-ECMO decannulation with the Manta vascular closure device. We performed a meta-analysis of proportions on outcome measures, including technical success, bleeding complications, vascular complications, wound complications, major amputation, and procedural-related deaths. We included seven studies with a total of 116 patients. The overall technical success of percutaneous decannulation of VA-ECMO with the Manta vascular closure device was 93.7%. The overall incidence of bleeding, vascular and wound complications was 1.7%, 13.8%, and 3.4%, respectively. No patient required lower limb amputation or died due to VA-ECMO decannulation. Percutaneous decannulation with the Manta vascular closure device is an effective and safe procedure that should be considered in suitable patients on VA-ECMO.